CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis

J Immunol. 1998 Apr 15;160(8):3627-30.

Abstract

Synthetic oligodeoxynucleotides containing CpG dinucleotides (CpG-ODN) mimic the immunostimulatory qualities of bacterial DNA. We asked whether immunostimulation by CpG-ODN predisposes for a commitment toward a Th1 vs a Th2 response in Leishmania major infection, a model for a lethal Th2-driven disease, in BALB/c mice. CpG-ODN induced Th1 effector T cells in vitro and conveyed protective immunity to disease-prone BALB/c mice in vivo. Conversion to a Th1-driven resistant phenotype was associated with IL-12 production and maintained the expression of IL-12R beta2-chains. Most strikingly, CpG-ODN were even curative when given as late as 20 days after lethal L. major infection, indicating that CpG-ODN revert an established Th2 response. These findings imply an important role of bacterial DNA and CpG-ODN in the instruction of adaptive immune responses. They also point to the therapeutic potential of CpG-ODN in redirecting curative Th1 responses in Th2-driven disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Base Sequence
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology
  • CpG Islands*
  • DNA Primers / genetics
  • Female
  • In Vitro Techniques
  • Interleukin-12 / pharmacology
  • Interleukin-4 / antagonists & inhibitors
  • Leishmania major*
  • Leishmaniasis, Cutaneous / immunology*
  • Leishmaniasis, Cutaneous / therapy*
  • Mice
  • Mice, Inbred BALB C
  • Oligodeoxyribonucleotides / genetics
  • Oligodeoxyribonucleotides / pharmacology*
  • Polymerase Chain Reaction
  • Th1 Cells / drug effects*
  • Th1 Cells / immunology*
  • Th2 Cells / drug effects
  • Th2 Cells / immunology

Substances

  • DNA Primers
  • Oligodeoxyribonucleotides
  • Interleukin-12
  • Interleukin-4